Infiltrative Treatment of Morton's Neuroma: A Systematic Review.

Alcohol Capsaicin Corticosteroid Hyaluronic acid Injection Morton's neuroma

Journal

Pain management nursing : official journal of the American Society of Pain Management Nurses
ISSN: 1532-8635
Titre abrégé: Pain Manag Nurs
Pays: United States
ID NLM: 100890606

Informations de publication

Date de publication:
01 Jul 2024
Historique:
received: 03 01 2024
revised: 20 05 2024
accepted: 04 06 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 2 7 2024
Statut: aheadofprint

Résumé

Morton's neuroma (MN) is one of the most frequent neurological pathologies in feet, affecting approximately 4% of the general population. The treatment of MN can be surgical, conservative, and infiltrative, with different substances used in the injections for MN, as steroids, sclerosing solutions, and others. This review aims to evaluate the efficacy of current infiltrative therapy for Morton's neuroma and, additionally, to define adverse effects of this therapy. A literature search was performed in PubMed, Embase, CINHAL, Epistemonikos, Web of Science (WOS), SPORTSDiscus and Cochrane Library. This search involved the application of all types of infiltrative treatment applicable to MN. The search was limited to original data describing clinical outcomes and pain using the Visual Analogue pain Scale (VAS) or the Johnson Satisfaction Scale, between February and June 2023. Twelve manuscripts were selected (six randomized controlled trials and six longitudinal observational studies) involving 1,438 patients. Capsaicin was reported to produce a VAS score reduction of 51.8%. Corticosteroids also reported a high level of efficacy. Alcohol and Hyaluronic Acid injections are well tolerated, but the effects of their application need further research. There were no serious adverse events. Corticosteroids, sclerosant injections, hyaluronic acid and capsaicin have been shown to be effective in reducing the pain related to MN.

Sections du résumé

BACKGROUND BACKGROUND
Morton's neuroma (MN) is one of the most frequent neurological pathologies in feet, affecting approximately 4% of the general population. The treatment of MN can be surgical, conservative, and infiltrative, with different substances used in the injections for MN, as steroids, sclerosing solutions, and others. This review aims to evaluate the efficacy of current infiltrative therapy for Morton's neuroma and, additionally, to define adverse effects of this therapy.
MATERIAL AND METHODS METHODS
A literature search was performed in PubMed, Embase, CINHAL, Epistemonikos, Web of Science (WOS), SPORTSDiscus and Cochrane Library. This search involved the application of all types of infiltrative treatment applicable to MN. The search was limited to original data describing clinical outcomes and pain using the Visual Analogue pain Scale (VAS) or the Johnson Satisfaction Scale, between February and June 2023.
RESULTS RESULTS
Twelve manuscripts were selected (six randomized controlled trials and six longitudinal observational studies) involving 1,438 patients. Capsaicin was reported to produce a VAS score reduction of 51.8%. Corticosteroids also reported a high level of efficacy. Alcohol and Hyaluronic Acid injections are well tolerated, but the effects of their application need further research. There were no serious adverse events.
CONCLUSIONS CONCLUSIONS
Corticosteroids, sclerosant injections, hyaluronic acid and capsaicin have been shown to be effective in reducing the pain related to MN.

Identifiants

pubmed: 38955553
pii: S1524-9042(24)00190-5
doi: 10.1016/j.pmn.2024.06.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

Auteurs

María Oliva Millán-Silva (MO)

Departamento de Podología. University of Seville, Seville, Spain.

Pedro V Munuera-Martínez (PV)

Departamento de Podología. University of Seville, Seville, Spain. Electronic address: pmunuera@us.es.

Priscila Távara-Vidalón (P)

Departamento de Podología. University of Seville, Seville, Spain.

Classifications MeSH